Financials Aurora Cannabis Inc. Nasdaq

Equities

ACB

CA05156X8504

Pharmaceuticals

Real-time Estimate Cboe BZX 15:17:25 2024-06-17 EDT 5-day change 1st Jan Change
5.735 USD -0.09% Intraday chart for Aurora Cannabis Inc. -2.72% +20.33%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,067 1,473 2,314 1,070 321.6 429.3 - -
Enterprise Value (EV) 1 12,396 1,842 2,292 858.3 248.3 429.3 429.3 429.3
P/E ratio -41.7 x -0.45 x -2.85 x -0.62 x -1.52 x -5.03 x -48.4 x 69.4 x
Yield - - - - - - - -
Capitalization / Revenue 48.7 x 5.28 x 9.43 x 4.83 x 1.84 x 1.58 x 1.34 x 1.17 x
EV / Revenue 48.7 x 5.28 x 9.43 x 4.83 x 1.84 x 1.58 x 1.34 x 1.17 x
EV / EBITDA -77.4 x -7.17 x -20.3 x -21 x -57.2 x 27.4 x 14.2 x 8.83 x
EV / FCF -19.9 x -2.13 x -8.78 x -7.53 x -2.52 x -6.23 x -29 x 13.8 x
FCF Yield -5.03% -47% -11.4% -13.3% -39.7% -16% -3.45% 7.22%
Price to Book 2.8 x - - - - - - -
Nbr of stocks (in thousands) 8,317 9,741 19,798 21,477 34,213 54,546 - -
Reference price 2 1,451 151.2 116.9 49.80 9.400 7.870 7.870 7.870
Announcement Date 19-09-11 20-09-22 21-09-27 22-09-20 23-06-14 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 247.9 278.9 245.5 221.3 175 272 319.6 367.3
EBITDA 1 -156 -205.3 -114.1 -51.05 -5.625 15.68 30.14 48.62
EBIT 1 -338.6 -491 -282.8 -231.4 -158.1 -46.76 -11.68 15.62
Operating Margin -136.58% -176.03% -115.21% -104.57% -90.36% -17.19% -3.65% 4.25%
Earnings before Tax (EBT) 1 -328.2 -3,384 -699.8 -1,720 -221.5 -75.98 -1.392 22.9
Net income 1 -290.8 -3,310 -695.1 -1,718 -199 -61.91 -7.752 5.591
Net margin -117.3% -1,186.9% -283.17% -776% -113.73% -22.76% -2.43% 1.52%
EPS 2 -34.80 -339.4 -41.00 -79.90 -6.200 -1.566 -0.1625 0.1133
Free Cash Flow 1 -606.5 -693 -263.7 -142.1 -127.8 -68.87 -14.8 31
FCF margin -244.61% -248.46% -107.41% -64.18% -73.03% -25.32% -4.63% 8.44%
FCF Conversion (EBITDA) - - - - - - - 63.75%
FCF Conversion (Net income) - - - - - - - 554.5%
Dividend per Share - - - - - - - -
Announcement Date 19-09-11 20-09-22 21-09-27 22-09-20 23-06-14 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 60.59 50.43 50.22 49.26 61.68 61.68 64.03 75.11 63.42 64.42 69.54 85.91 74.52 76.61 82.89
EBITDA 1 -9.04 -12.26 -12.85 -8.7 1.428 1.428 0.31 2.155 3.398 4.349 5.764 7.67 6.804 7.067 10.27
EBIT 1 -55.79 -72.38 -63.9 -53.82 -71.6 -71.6 -32.68 -16.11 -11.05 -23.89 -1.2 - - - -
Operating Margin -92.09% -143.52% -127.25% -109.26% -116.08% -116.08% -51.05% -21.45% -17.42% -37.09% -1.73% - - - -
Earnings before Tax (EBT) 1 -75.51 -1,012 -620.1 -63.86 -67.28 -67.28 -90.39 -22.11 0.384 -25.28 -3.629 - - - -
Net income 1 -74.78 -1,012 -618.8 -51.6 -65.39 -67.2 -82 -26.9 -0.523 -25.56 -3.179 - - - -
Net margin -123.42% -2,006.93% -1,232.28% -104.75% -106.02% -108.95% -128.07% -35.81% -0.82% -39.68% -4.57% - - - -
EPS 2 -3.800 -47.20 -25.90 -1.700 -2.000 -2.000 -2.500 -0.8000 - -0.5000 -0.0800 - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 22-02-10 22-05-12 22-09-20 22-11-10 23-02-10 23-02-09 23-06-14 23-08-10 23-11-09 24-02-08 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 329 369 - - - - - -
Net Cash position - - 21.9 211 73.3 - - -
Leverage (Debt/EBITDA) -2.108 x -1.797 x - - - - - -
Free Cash Flow 1 -606 -693 -264 -142 -128 -68.9 -14.8 31
ROE (net income / shareholders' equity) -9.8% -11.7% -12.4% -11.6% - -4.9% -0.8% 4.3%
ROA (Net income/ Total Assets) -7.87% -9.21% -9.65% -8.46% - -2.7% -0.4% 2.2%
Assets 1 3,695 35,943 7,205 20,315 - 2,293 1,938 254.1
Book Value Per Share 518.0 - - - - - - -
Cash Flow per Share 2 -22.70 -34.60 -12.50 -5.110 - -0.0600 0.2200 0.7800
Capex 1 414 355 53.1 32.2 12.1 13.1 11.9 9.99
Capex / Sales 167.1% 127.29% 21.62% 14.55% 6.93% 4.83% 3.72% 2.72%
Announcement Date 19-09-11 20-09-22 21-09-27 22-09-20 23-06-14 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
7.87 CAD
Average target price
9.681 CAD
Spread / Average Target
+23.01%
Consensus
  1. Stock Market
  2. Equities
  3. ACB Stock
  4. ACB Stock
  5. Financials Aurora Cannabis Inc.